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Abstract: Cytokines such as Interleukin 12 (IL-12) and Interleukin 17(IL-
17) influence the function of the immune system and different tissues and 
are studied due to the role they play in Multiple Sclerosis (MS). The aim 
of the study was to investigate the effect of aqua-therapy on plasma IL-12 
and IL-17 in patients with MS. 25 men with MS were divided into two 
groups: exercise and control. Blood sample was taken before and after the 
intervention protocol. The exercise group carried out three exercise sessions 
per week during eight weeks. The beginning and final parts of each session 
included warming up and cool down, and were carried out in shallow areas. 
These activities were designed and implemented by a researcher under the 
supervision of a sports physiologist and an experienced neurologist. During 
the training sessions, the first 10 minutes were for warming up, and the last 
5 minutes of training were for cool down. Exercise intensity was approxima-
tely 75% of heart rate reserve. The data demonstrated that both IL-12 and 
IL-17 decreased significantly from pre-test to post-test in the exercise group. 
We conclude that aqua-training may reduce risk factors regarding multiple 
sclerosis, including IL-12 and IL-17.
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Resumen: Las citocinas como la interleucina-12 (IL-12) y la interleucina-17 
(IL-17) influyen en la función del sistema inmune y los diferentes tejidos, 
siendo estudiadas debido al papel que desempeñan en la Esclerosis Múlti-
ple (EM). El objetivo de este estudio fue investigar el efecto de la terapia 
acuática en la IL-12 y la IL-17 en pacientes con esclerosis múltiple. Par-
ticiparon 25 hombres con esclerosis múltiple, los cuales fueron divididos 
en dos grupos: ejercicio y control. Se tomó una muestra de sangre antes y 
después de la intervención. El grupo de ejercicio llevó a cabo tres sesiones 
por semana durante ocho semanas. Las partes inicial y final de cada se-
sión incluyeron calentamiento y vuelta a la calma, llevadas a cabo en zonas 
poco profundas. Las actividades fueron diseñadas y llevadas a cabo por un 
investigador bajo la supervisión de un fisiólogo deportivo y un neurólogo 
experimentado. Durante las sesiones de entrenamiento, se dedicaban los 
primeros 10 minutos al calentamiento y los últimos 5 minutos a la vuelta 
a la calma. La intensidad del ejercicio fue aproximadamente del 75% de la 
frecuencia cardíaca máxima. Los datos demostraron que tanto IL-12 como 
IL-17 disminuyeron significativamente entre el pre-test y el post-test. Por 
tanto, se concluye que la terapia acuática puede reducir los factores de riesgo 
con respecto a la esclerosis múltiple, incluidas la IL-12 y la IL-17. 
Palabras clave: agua, ejercicio, esclerosis múltiple, interleucina.
Introduction
Multiple sclerosis is characterized by triple inflammation, 
myelination, and gliosis (Chae & Bothwell, 2018). The cour-
se of the disease may be recurring and progressive. MS scans 
are typically published in terms of time and position. MS 
has involved around 350,000 Americans and 1.1 million 
people around the world (Stamatelos & Anagnostouli, 2017). 
In Western societies, MS is ranked second only to neurolo-
gic disabilities in the early to mid-adult years after trauma. 
MS demonstrations range from a benign disease to a rapidly 
progressive and debilitating disease that requires a significant 
change in lifestyle. According to the studies, exercise and the-
rapeutic exercises play an important role in treating MS, and 
exercise exercises improve the symptoms of the disease, given 
that it is unclear what kind of exercise and how intensive and 
time it takes to improve MS patients. Therefore, the present 
study intends to investigate whether the aqueous exercises 
affect some motor disorders of autistic patients with MS (Pa-
nitch, Hirsch, Schindler, & Johnson, 1987).
Cytokines impress the role of the immune system, the 
cardiovascular system of the body and various tissues and 
are studied due to the role they play in MS (Segal & Sheva-
ch, 1996). A change in the cytokine secretion pattern, often 
secreted by immune cells, is features that can help experts 
predict the condition. Injection of interferon gamma into 
MS causes an attack. Research has proven that the level of 
interferon-gamma serum levels increases before relapse, and 
it is affirmed that activity and recurrence of the disease are 
primarily related to Th1 activity (Li et al., 2006). Interleukin 
12, 17, and 23 are also effective factors in the incidence of 
MS. Researchers have associated interleukin-12 with chan-
ges in MRI. It is believed to be effective in patients with a 
lower level of IL-12 mRNA, a disease novel with interferon 
90 S. Nejatpour et al.
SPORT TK: Revista Euroamericana de Ciencias del Deporte
ISSN edición web: 2340-8812 / vol. 8, n.º 1 / Murcia / Enero 2019 / Págs. 89-94
The effect of aqua-therapy on plasma and interleukin-12 and 17 in patients with 
SPORT TK, 8(1), 89-94
beta (Bryan, 2018). The level of IL-17 production has a di-
rect relation with the patient’s activity and is reduced by the 
treatment with interferon beta. A notable point is that in 
people who have recently been diagnosed with their disease, 
they have more levels of interleukin 17 than the other pa-
tients (Komiyama et al., 2006).
Several reports have reported the reduction of interferon 
and interleukins in the development of MS (Moller et al., 
1996). In an under-medication and double-blind, subcuta-
neous increase in interferon beta-1, the severity of deterio-
ration reduced the severity of brain damage in MRI images 
(Chtara et al., 2005). Accordingly, the US Food and Drug 
Administration used it somehow in the treatment of MS. 
It has also been suggested that elevated beta levels due to 
diet can improve motor distress in MS patients. Based on 
the results, caloric restriction can prevent unknowns from 
the occurrence of MS and affect its early levels (Gendel-
man& Benner, 2017). Since physical activity and exercise 
are some of the limitations of calories, the researchers ques-
tion the question of whether physical activity can reduce 
interferon-gamma and interleukin 12, 17 and 23 (Des-
hpande, King, & Segal, 2006). Jiang & Pernis conducted 
a 3-month training program on MS patients and observed 
a relative improvement in EDSS in MS patients (Jiang & 
Pernis, 1992). Kraemer et al. (2002) concluded that a re-
lative improvement in EDSS in MS patients occurs after 
six weeks of training (Kraemer et al., 2002). In another 
study, Frzovic et al (2000) found that an aerobic and the-
rapeutic activity period had a significant effect on EDSS 
in MS patients (Frzovic, Morris, & Vowels, 2000; Panitch 
et al., 1987). Hesse et al. (2011), after one year of training 
on MS patients, concluded that interleukin-12 was slightly 
reduced and cortisol concentrations increased (Arnason et 
al., 1999; Hesse et al., 2011). Research in 2016 states that 
after eight weeks of aerobic training in the MS group, IL-6 
decreased and these exercises may improve the body’s de-
fensive mechanisms in resting state on MS patients (Arna-
son et al., 1999). Hydrotherapy is a combination of exercise 
and exercise therapy in physiotherapy, it is a comprehensive 
examination therapeutic approach that assists with several 
rehabilitation treatments using water exercises (Hauser et 
al., 2008). Nowadays, water is conceived as a therapeutic 
and rehabilitation method. Education for rehabilitation 
in many diseases with symptoms of pain, muscle stiffness 
and balance imbalance, reduced range of movement, motor 
growth retardation and even the relief of some psycholo-
gical symptoms are used (Chae & Bothwell, 2018; López, 
Nicolás, & Díaz, 2018). As it has been reported that aqua 
therapy may improve inflammation and function of patient 
with multiple sclerosis, we are interested to clarify if it im-
prove via reduction in interferon gamma and interleukin 
23. Hence the aim of this study was to investigate the effect 
of aqua-therapy on plasma interferon gamma and interleu-
kin-23 in patient with multiple sclerosis.
Methods
Participants
The statistical population of this study was the patients with 
multiple sclerosis with EDSS2.5 to 5 with a degree of Ataxia 
and referred to the MS Society of Mashhad. The Expanded 
Disability Status Scale (EDSS) is a method of quantifying 
disability in multiple sclerosis and monitoring changes in the 
level of disability over time. It is widely used in clinical trials 
and in the assessment of people with MS. EDSS of patients 
were already assigned by the neurologist. After that Ataxia 
was diagnosed by the neurologist. Patients with orthopedic 
problems, patients with underlying illnesses such as diabe-
tes, heart problems and blood pressure, and those who used 
tobacco, and other neurological diseases were excluded from 
the group through a form of information that was provided 
from the patient’s history. In addition to the above, patients 
who participated in regular exercise programs were also ex-
cluded from the research group. Then the patients filled the 
conditions, the consent form and the cooperation. Finally 
the subjects of this study were twenty-five men with multiple 
sclerosis (EDSS 2.5 to 5), who had a Ataxia degree introdu-
ced by the Mashhad MS Society. There was no significant 
difference between the groups in this regard. The 25 selected 
subjects were divided into two groups of exercise and control. 
The samples were taken before and after the protocol.
Aqua training program
At the first session of training, the subjects were accustomed 
to the circumstance of the pool. Recommendations about Sa-
fety were commented to lower any risk during operation of 
the protocol, such as fall. To floating the patients easily, exer-
cise belts was utilize for maintaining balance and benefiting 
from deep water. The belt was first taught to patients. The 
first few exercises were performed to patients’ familiarization 
with aqua training in shallow water. The beginning and final 
stages of each session included warming up and cool down, 
carried out in shallow areas. These operations were designed 
and carried out by a researcher under the supervision of a 
sports physiologist and an experienced neurologist. During 
the training sessions, 10 minutes of warming up, and the last, 
5 minutes of training to cool down were operated. Exercise 
intensity was approximately 75% of heart rate reserve. The 
men were asked to rest for 5 minutes between each stage 
of their training, which felt tired, and then resume exercise 
again.
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Variables Measurement
ELISA kits specific for the human were utilized to assess 
plasma Interleukin 12 and 17 (Hangzhou, Eastbiopharm Co., 
Ltd., China).
Statistical analyses
Shapiro-Wilk test was used to determine distribution norma-
lity which was found to be distributed normally. One-way 
analysis of variance (ANOVA) with repeated measures was 
applied to determine the differences in variables among the 
groups. Significant differences were identified using (LSD) 
post-hoc test by using SPSS version 16. All data were expres-
sed as mean ± SD and significance was set at the alpha level 
p < 0.05.
Results
There was no significant difference between the pre-test and 
post-test scores in the control group and interleukin 12 re-
mained unchanged in this group, while the difference in 
the exercise group is completely significant at the 5% error 
level. In other words, in the exercise group, Interleukin 12 
with a mean of 1.30 in post-test was significantly less than 
the pre-test mean. It is clear that the values of IL-12 in exer-
cise group decreased significantly from pre-test to post-test. 
Also there was no significant difference between the pre-test 
and post-test scores in the control group and interleukin 17 
remained unchanged in this group, while the difference in 
the exercise group is completely significant at the 5% error 
level. In other words, in the exercise group, interleukin 17 
with a mean of 2.29 in post-test was significantly less than 
the pre-test mean. It is clear that the values of interleukin 
17 in exercise group decreased significantly from pre-test to 
post-test. (Table 1).
Table 1. Differences between pre-test and post-test.
Variables Groups Pre Mean ±SD Post Mean ±SD
Interleukin 12 Exercise group 1.50±0.28 1.30±0.12
Control 1.88±0.54 1.97±0.69
Interleukin 17 Exercise group 4.62±1.37 2.29±1.34
Control 3.92±2.67 3.97±1.69
Discussion
Several studies have reported the reduction of interferons and 
interleukins in the development of MS. In an under-medica-
tion and double-blind, subcutaneous increase in interferon 
beta-1, the severity of deterioration reduced the severity of 
brain damage in MRI images. Accordingly, the US Food 
and Drug Administration used it somehow in the treatment 
of MS (Brok et al., 2002). It has also been suggested that 
elevated beta levels, due to the appropriate diet, can improve 
motor distress in MS patients. Based on the results, caloric 
restriction can prevent unknowns from the occurrence of 
MS and affect its early levels. Because exercise and exercise 
are one of the forms of calorie restriction (Komiyama et al., 
2006).
Jiang & Pernis (1992) conducted a 3-month training pro-
gram on MS patients and observed a relative improvement 
in EDSS in MS patients (Jiang & Pernis, 1992). Kraemer et 
al. (2002) concluded that a relative improvement in EDSS in 
MS patients occurs after six weeks of training (Kraemer et 
al., 2002). In another study, Frzovic (2000) found that an ae-
robic and therapeutic activity period had a significant effect 
on EDSS in MS patients (Deshpande et al., 2006; Frzovic et 
al., 2000). Hesse et al. (2011), after one year of training on 
MS patients, concluded that interleukin-12 was slightly redu-
ced and cortisol concentrations increased (Hesse et al., 2011). 
The Interleukin 12 and 17 dimer consists of two subunits, P 
4235, because the unit before the game unit P19 interleukin 
23 forms a complex that together with the formation of a uni-
que subset of Interleukin 17 and the differentiation of th17 
cells (Grifka-Walk & Segal, 2017).
As noted earlier, researchers have found that interleu-
kin-12 levels are related to the disease’s activity and altera-
tions in MRI. In patients with MS who have a lower level 
of transcription of the p35 and IL-12 gene, treatment with 
interferon beta is more effective than this marker. Prognosis 
is accurately predicted in 81% of patients and patients, and 
it is also clear that after treatment with certain drugs, the 
level of interleukin 12 also decreases significantly (Moller et 
al., 1996).
The level of IL-17 production has a direct relation with the 
disease activity and is lowered by treatment with interferon 
beta. The novelty 3 is considered here in patients who have 
recently been diagnosed with MS, compared to patients who 
have long been exposed to this The disease has been interfe-
ring with the level of interleukin 17 production, which can 
be attributed to the high level of interleukin 17 with activity 
and severity of the disease (Kleinschmidt-DeMasters & Tyler, 
2005). It is worth noting that the activity and severity of the 
disease are in patients who have long been involved in MS. It 
reaches to the equilibrium Ten people who do not respond to 
treatment with beta interferon has high serum levels of IL-17 
(Pravenec et al., 2003).
Many of the subsequent studies showed an increase in 
the concentration of different cytokines after a long-term 
exercise. Increases in circulating concentrations of pro-in-
flammatory cytokines (such as IL-1β and TNFα and IL-
12), anti-inflammatory (such as IL-6 and IL-10), cytokine 
inhibitors (such as IL-1 and TNF receptors α), chemokine’s 
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(e.g., tetrafluorine gamma-IL-8, inflammatory macrophage 
protein, and chemo-monocyte-1 protein and colony stimu-
lants after endurance exercise have been reported (Donges, 
Duffield, & Drinkwater, 2010). However, the increase in 
IL-6 concentration in circulation after long-term exercise 
is fully characterized and sustained, but the response from 
exercise to any other cytokine requires a lot of research. Re-
lease of cytokines during and after exercise may be a pro-
tective mechanism for coping with general inhibition of 
post-exercise safety responses. In addition, many of the acu-
te phase proteins released in response to increased levels of 
cytokines, and protease inhibitors or free radical cleansers, 
limit the tissue lesions resulting from toxic molecules and 
free radicals of active neutrophils (Giannopoulou et al., 
2005; Kadoglou et al., 2007).
Conclusion
The result of this study suggests that aqua-training may re-
duce risk factors regarding multiple sclerosis, including inter-
leukin-12 and 17.
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